WINTON GROUP Ltd Sells 11,194 Shares of Merit Medical Systems, Inc. $MMSI

WINTON GROUP Ltd lessened its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 7.0% in the 2nd quarter, Holdings Channel.com reports. The firm owned 147,589 shares of the medical instruments supplier’s stock after selling 11,194 shares during the quarter. WINTON GROUP Ltd’s holdings in Merit Medical Systems were worth $10,234,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of MMSI. Integrated Wealth Concepts LLC purchased a new stake in Merit Medical Systems during the 2nd quarter valued at about $199,000. Squarepoint Ops LLC increased its stake in Merit Medical Systems by 17.2% during the 2nd quarter. Squarepoint Ops LLC now owns 27,458 shares of the medical instruments supplier’s stock valued at $1,904,000 after purchasing an additional 4,020 shares in the last quarter. Allworth Financial LP raised its holdings in Merit Medical Systems by 1,661.5% in the second quarter. Allworth Financial LP now owns 1,920 shares of the medical instruments supplier’s stock worth $133,000 after buying an additional 1,811 shares during the last quarter. Arizona State Retirement System raised its holdings in Merit Medical Systems by 1.1% in the second quarter. Arizona State Retirement System now owns 16,459 shares of the medical instruments supplier’s stock worth $1,141,000 after buying an additional 174 shares during the last quarter. Finally, Nykredit A S bought a new position in shares of Merit Medical Systems in the second quarter worth approximately $210,000. Institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Trading Down 0.2%

Merit Medical Systems stock opened at $87.19 on Thursday. Merit Medical Systems, Inc. has a 52-week low of $59.74 and a 52-week high of $94.75. The company has a market cap of $5.21 billion, a P/E ratio of 36.03, a P/E/G ratio of 2.18 and a beta of 0.49. The company has a quick ratio of 2.79, a current ratio of 4.20 and a debt-to-equity ratio of 0.44. The business has a 50-day simple moving average of $82.95 and a two-hundred day simple moving average of $73.29.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.23. The firm had revenue of $418.84 million for the quarter, compared to analysts’ expectations of $405.25 million. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The business’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Analysts predict that Merit Medical Systems, Inc. will post 3.84 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on MMSI. BTIG Research reiterated a “buy” rating and set a $105.00 price target on shares of Merit Medical Systems in a report on Tuesday, August 11th. Robert W. Baird set a $98.00 price objective on shares of Merit Medical Systems in a report on Friday, July 31st. Raymond James Financial reaffirmed an “outperform” rating and issued a $100.00 price objective on shares of Merit Medical Systems in a research report on Friday, July 31st. Zacks Research upgraded Merit Medical Systems from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 25th. Finally, Barrington Research set a $114.00 target price on Merit Medical Systems in a report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $100.00.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.